# Flexible Solutions International Inc: financial statements, quarterly

FSI · NYSE · CIK 1069394 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fsi.md) · [Financials](/companies/fsi/financials.md) · [Filings](/companies/fsi/filings.md) · [Insiders](/companies/fsi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fsi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8.7](/filings/0001493152-24-045777.md) | [9.4 d](/filings/0001641172-25-001675.md) | [9.2](/filings/0001641172-25-010832.md) | [10.5](/filings/0001641172-25-023966.md) | [9.3](/filings/0001493152-25-023546.md) | [9.2 d](/filings/0001493152-26-016796.md) | [7.5](/filings/0001493152-26-023701.md) | [11.4](/filings/0001493152-26-038290.md) | [10.6](/filings/0001493152-25-023546.md) | [9.1 d](/filings/0001493152-26-016796.md) | [8.3](/filings/0001493152-26-023701.md) | [7.6](/filings/0001493152-26-038290.md) |
| Cost of revenue | $m | [7.2](/filings/0001493152-24-045777.md) | [6.6 d](/filings/0001641172-25-001675.md) | [6.4](/filings/0001641172-25-010832.md) | [6.6](/filings/0001641172-25-023966.md) | [5.5](/filings/0001493152-25-023546.md) | [6.5 d](/filings/0001493152-26-016796.md) | [5.5](/filings/0001493152-26-023701.md) | [6.0](/filings/0001493152-26-038290.md) | [8.0](/filings/0001493152-25-023546.md) | [6.4 d](/filings/0001493152-26-016796.md) | [6.4](/filings/0001493152-26-023701.md) | [7.9](/filings/0001493152-26-038290.md) |
| Gross profit | $m | [1.5](/filings/0001493152-24-045777.md) | [2.8 d](/filings/0001641172-25-001675.md) | [2.8](/filings/0001641172-25-010832.md) | [3.9](/filings/0001641172-25-023966.md) | [3.8](/filings/0001493152-25-023546.md) | [2.7 d](/filings/0001493152-26-016796.md) | [2.0](/filings/0001493152-26-023701.md) | [5.4](/filings/0001493152-26-038290.md) | [2.5](/filings/0001493152-25-023546.md) | [2.7 d](/filings/0001493152-26-016796.md) | [1.9](/filings/0001493152-26-023701.md) | [(0.3)](/filings/0001493152-26-038290.md) |
| Research and development | $m | [0.1](/filings/0001493152-24-045777.md) | [0.1 d](/filings/0001641172-25-001675.md) | [0.1](/filings/0001641172-25-010832.md) | [0.1](/filings/0001641172-25-023966.md) | [0.0](/filings/0001493152-25-023546.md) | [0.1 d](/filings/0001493152-26-016796.md) | [0.1](/filings/0001493152-26-023701.md) | [0.2](/filings/0001493152-26-038290.md) | [0.3](/filings/0001493152-25-023546.md) | [0.1 d](/filings/0001493152-26-016796.md) | [0.1](/filings/0001493152-26-023701.md) | [0.1](/filings/0001493152-26-038290.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.8](/filings/0001493152-26-023701.md) | [0.8](/filings/0001493152-26-038290.md) | not reported | not reported | [0.8](/filings/0001493152-26-023701.md) | [0.5](/filings/0001493152-26-038290.md) |
| Operating income | $m | [(0.4)](/filings/0001493152-24-045777.md) | [1.7 d](/filings/0001641172-25-001675.md) | [0.8](/filings/0001641172-25-010832.md) | [2.0](/filings/0001641172-25-023966.md) | [1.9](/filings/0001493152-25-023546.md) | [0.9 d](/filings/0001493152-26-016796.md) | [(0.1)](/filings/0001493152-26-023701.md) | [3.3](/filings/0001493152-26-038290.md) | [0.3](/filings/0001493152-25-023546.md) | [1.1 d](/filings/0001493152-26-016796.md) | [(0.1)](/filings/0001493152-26-023701.md) | [(2.2)](/filings/0001493152-26-038290.md) |
| Interest expense | $m | [0.1](/filings/0001493152-23-041043.md) | [0.1 d](/filings/0001493152-24-012435.md) | [0.2](/filings/0001493152-24-019962.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.2](/filings/0001493152-24-045777.md) | [(1.0) d](/filings/0001641172-25-001675.md) | [0.3](/filings/0001641172-25-010832.md) | [0.6](/filings/0001641172-25-023966.md) | [0.4](/filings/0001493152-25-023546.md) | [(0.3) d](/filings/0001493152-26-016796.md) | [0.1](/filings/0001641172-25-010832.md) | [1.0](/filings/0001641172-25-023966.md) | [(0.2)](/filings/0001493152-25-023546.md) | [(0.0) d](/filings/0001493152-26-016796.md) | not reported | not reported |
| Net income | $m | [(0.7)](/filings/0001493152-24-045777.md) | [1.8 d](/filings/0001641172-25-001675.md) | [0.5](/filings/0001641172-25-010832.md) | [1.3](/filings/0001641172-25-023966.md) | [0.6](/filings/0001493152-25-023546.md) | [0.7 d](/filings/0001493152-26-016796.md) | [(0.3)](/filings/0001493152-26-023701.md) | [2.0](/filings/0001493152-26-038290.md) | [(0.5)](/filings/0001493152-25-023546.md) | [(0.5) d](/filings/0001493152-26-016796.md) | [(0.2)](/filings/0001493152-26-023701.md) | [(1.9)](/filings/0001493152-26-038290.md) |
| Diluted EPS | $ per share | [(0.06)](/filings/0001493152-24-045777.md) | not reported | [0.04](/filings/0001641172-25-010832.md) | [0.10](/filings/0001641172-25-023966.md) | [0.05](/filings/0001493152-25-023546.md) | not reported | [(0.02)](/filings/0001493152-26-023701.md) | [0.15](/filings/0001493152-26-038290.md) | [(0.04)](/filings/0001493152-25-023546.md) | not reported | [(0.02)](/filings/0001493152-26-023701.md) | [(0.15)](/filings/0001493152-26-038290.md) |
| Basic EPS | $ per share | [(0.06)](/filings/0001493152-24-045777.md) | not reported | [0.04](/filings/0001641172-25-010832.md) | [0.10](/filings/0001641172-25-023966.md) | [0.05](/filings/0001493152-25-023546.md) | not reported | [(0.02)](/filings/0001493152-26-023701.md) | [0.16](/filings/0001493152-26-038290.md) | [(0.04)](/filings/0001493152-25-023546.md) | not reported | [(0.02)](/filings/0001493152-26-023701.md) | [(0.15)](/filings/0001493152-26-038290.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [8.9](/filings/0001493152-24-045777.md) | [5.0](/filings/0001641172-25-001675.md) | [5.3](/filings/0001641172-25-010832.md) | [6.8](/filings/0001641172-25-023966.md) | [10.6](/filings/0001493152-24-045777.md) | [7.6](/filings/0001641172-25-001675.md) | [9.6](/filings/0001641172-25-010832.md) | [8.6](/filings/0001641172-25-023966.md) | [8.5](/filings/0001493152-25-023546.md) | [6.6](/filings/0001493152-26-038290.md) | [5.8](/filings/0001493152-26-023701.md) | [7.2](/filings/0001493152-26-038290.md) |
| Current assets | $m | [28.2](/filings/0001493152-23-041043.md) | [30.2](/filings/0001641172-25-001675.md) | [32.5](/filings/0001493152-24-019962.md) | [28.9](/filings/0001493152-24-032358.md) | [32.3](/filings/0001493152-24-045777.md) | [34.6](/filings/0001493152-26-016796.md) | [36.1](/filings/0001641172-25-010832.md) | [31.1](/filings/0001641172-25-023966.md) | [32.9](/filings/0001493152-25-023546.md) | [32.9](/filings/0001493152-26-038290.md) | [34.2](/filings/0001493152-26-023701.md) | [29.0](/filings/0001493152-26-038290.md) |
| Total assets | $m | [53.1](/filings/0001493152-23-041043.md) | [55.5](/filings/0001641172-25-001675.md) | [57.6](/filings/0001493152-24-019962.md) | [56.3](/filings/0001493152-24-032358.md) | [57.8](/filings/0001493152-24-045777.md) | [60.0](/filings/0001493152-26-016796.md) | [61.7](/filings/0001641172-25-010832.md) | [58.2](/filings/0001641172-25-023966.md) | [58.4](/filings/0001493152-25-023546.md) | [61.8](/filings/0001493152-26-038290.md) | [63.9](/filings/0001493152-26-023701.md) | [59.0](/filings/0001493152-26-038290.md) |
| Current liabilities | $m | [9.0](/filings/0001493152-23-041043.md) | [10.1](/filings/0001641172-25-001675.md) | [11.9](/filings/0001493152-24-019962.md) | [10.9](/filings/0001493152-24-032358.md) | [10.2](/filings/0001493152-24-045777.md) | [11.9](/filings/0001493152-26-016796.md) | [13.3](/filings/0001641172-25-010832.md) | [9.2](/filings/0001641172-25-023966.md) | [11.1](/filings/0001493152-25-023546.md) | [10.8](/filings/0001493152-26-038290.md) | [13.4](/filings/0001493152-26-023701.md) | [10.3](/filings/0001493152-26-038290.md) |
| Total liabilities | $m | [16.6](/filings/0001493152-23-041043.md) | [17.2](/filings/0001641172-25-001675.md) | [18.5](/filings/0001493152-24-019962.md) | [17.3](/filings/0001493152-24-032358.md) | [17.5](/filings/0001493152-24-045777.md) | [18.6](/filings/0001493152-26-016796.md) | [19.9](/filings/0001641172-25-010832.md) | [15.7](/filings/0001641172-25-023966.md) | [15.4](/filings/0001493152-25-023546.md) | [19.0](/filings/0001493152-26-038290.md) | [21.3](/filings/0001493152-26-023701.md) | [18.1](/filings/0001493152-26-038290.md) |
| Long-term debt | $m | [7.0](/filings/0001493152-23-041043.md) | [6.8](/filings/0001641172-25-001675.md) | [6.3](/filings/0001493152-24-019962.md) | [6.1](/filings/0001493152-24-032358.md) | [7.1](/filings/0001493152-24-045777.md) | [6.6](/filings/0001493152-26-016796.md) | [6.5](/filings/0001641172-25-010832.md) | [6.4](/filings/0001641172-25-023966.md) | [4.1](/filings/0001493152-25-023546.md) | [4.0](/filings/0001493152-26-038290.md) | [3.9](/filings/0001493152-26-023701.md) | [3.8](/filings/0001493152-26-038290.md) |
| Current portion of debt | $m | [0.8](/filings/0001493152-23-041043.md) | [0.1](/filings/0001641172-25-001675.md) | [1.7](/filings/0001493152-24-019962.md) | [2.2](/filings/0001493152-24-032358.md) | [2.3](/filings/0001493152-24-045777.md) | [2.1](/filings/0001493152-26-016796.md) | [1.6](/filings/0001641172-25-010832.md) | [1.1](/filings/0001641172-25-023966.md) | [2.9](/filings/0001493152-25-023546.md) | [0.4](/filings/0001493152-26-038290.md) | [0.4](/filings/0001493152-26-023701.md) | [0.4](/filings/0001493152-26-038290.md) |
| Shareholders' equity | $m | [33.7](/filings/0001493152-23-041043.md) | [35.2](/filings/0001641172-25-001675.md) | [36.0](/filings/0001493152-24-019962.md) | [36.2](/filings/0001493152-24-032358.md) | [36.9](/filings/0001493152-24-045777.md) | [38.0](/filings/0001493152-26-016796.md) | [38.4](/filings/0001641172-25-010832.md) | [39.4](/filings/0001641172-25-023966.md) | [39.0](/filings/0001493152-25-023546.md) | [38.9](/filings/0001493152-26-038290.md) | [38.8](/filings/0001493152-26-023701.md) | [37.0](/filings/0001493152-26-038290.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [2,201 d](/filings/0001493152-24-045777.md) | [(4,012) d](/filings/0001641172-25-001675.md) | [(605)](/filings/0001641172-25-010832.md) | [5,915 d](/filings/0001641172-25-023966.md) | [2,478 d](/filings/0001493152-25-023546.md) | [(2,220) d](/filings/0001493152-26-016796.md) | [(544)](/filings/0001493152-26-023701.md) | [5,283 d](/filings/0001493152-26-038290.md) | [2,019 d](/filings/0001493152-25-023546.md) | [(2,975) d](/filings/0001493152-26-016796.md) | [(1,818)](/filings/0001493152-26-023701.md) | [5,313 d](/filings/0001493152-26-038290.md) |
| Capital expenditure | $k | [542 d](/filings/0001493152-24-045777.md) | [664 d](/filings/0001641172-25-001675.md) | [478](/filings/0001641172-25-010832.md) | [1,186 d](/filings/0001641172-25-023966.md) | [1,212 d](/filings/0001493152-25-023546.md) | [2,089 d](/filings/0001493152-26-016796.md) | [354](/filings/0001493152-26-023701.md) | [977 d](/filings/0001493152-26-038290.md) | [1,979 d](/filings/0001493152-25-023546.md) | [1,064 d](/filings/0001493152-26-016796.md) | [2,234](/filings/0001493152-26-023701.md) | [746 d](/filings/0001493152-26-038290.md) |
| Dividends paid | $k | [0.0 d](/filings/0001493152-24-045777.md) | [0.0 d](/filings/0001641172-25-001675.md) | not reported | not reported | [0.0 d](/filings/0001493152-25-023546.md) | [0.0 d](/filings/0001493152-26-016796.md) | not reported | not reported | [0.0 d](/filings/0001493152-25-023546.md) | [0.0 d](/filings/0001493152-26-016796.md) | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.4](/filings/0001493152-23-041043.md) | [12.5](/filings/0001493152-24-019962.md) | [12.5](/filings/0001493152-24-032358.md) | [12.5](/filings/0001493152-24-045777.md) | [12.4](/filings/0001641172-25-010832.md) | [12.5](/filings/0001641172-25-023966.md) | [12.7](/filings/0001493152-25-023546.md) | [12.6](/filings/0001493152-26-023701.md) | [13.3](/filings/0001493152-26-038290.md) | [12.7](/filings/0001493152-25-023546.md) | [12.7](/filings/0001493152-26-023701.md) | [12.7](/filings/0001493152-26-038290.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,772,498 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038290.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.